However, once released from postischemic dead or dying neural cells, Prx's lose antioxidant capacity, act as DAMPs of TLRs, and induce innate and adaptive immune responses by activating TLR signaling, triggering neuroinflammation and brain lesions in ischemic stroke [45]. The gene discussed is PRX; the disease is ischemic stroke.